Alexion gets EU green light for a pair of rare disease drugs

Damian Garde

European regulators are recommending approval for two treatments from , a victory for the biotech as it works to expand its stable of commercialized .

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS